Clinical Trial Update: BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating bone marrow mononuclear cells (BM-MNCs) and umbilical cord-derived mesenchymal stem cells (UC-MSCs) infusion for Type 2 D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BM-MNCs (bone marrow mononuclear cells)
• UC-MSCs (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Van Hanh General Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN